Charles River Laboratories (CRL) Tops Q4 EPS by 5c, Provides Guidance
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $0.73, $0.05 better than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
